UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 289

Sortiert nach

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

JAMA neurology, 2020-09, Vol.77 (9), p.1132

2020

Link zum Volltext

Verfügbarkeit prüfen

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

The New England journal of medicine, 2019-06, Vol.380 (25), p.2406-2417

2019

Link zum Volltext

Verfügbarkeit prüfen

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2016-03, Vol.387 (10023), p.1075-1084

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Annals of neurology, 2011-02, Vol.69 (2), p.292-302

2011

Link zum Volltext

Verfügbarkeit prüfen

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-03, Vol.13 (3), p.247-256

2014

Link zum Volltext

Verfügbarkeit prüfen

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

Lancet neurology, 2012-05, Vol.11 (5), p.467-476

2012

Link zum Volltext

Verfügbarkeit prüfen

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-10, Vol.13 (10), p.977-986

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Annals of neurology, 2013-03, Vol.73 (3), p.327-340

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

Annals of neurology, 2018-10, Vol.84 (4), p.527-536

2018

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Annals of neurology, 2005-12, Vol.58 (6), p.840-846

2005

Link zum Volltext

Verfügbarkeit prüfen

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Annals of neurology, 2001-07, Vol.50 (1), p.121-127

2001

Link zum Volltext

Verfügbarkeit prüfen

Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosis

The Journal of neuroscience, 2011-11, Vol.31 (46), p.16826-16832

2011

Link zum Volltext

Verfügbarkeit prüfen

Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis

Journal of magnetic resonance imaging, 2016-11, Vol.44 (5), p.1293-1300

2016

Link zum Volltext

Verfügbarkeit prüfen

Deep gray matter atrophy in multiple sclerosis: A tensor based morphometry

Journal of the neurological sciences, 2009-07, Vol.282 (1), p.39-46

2009

Link zum Volltext

Verfügbarkeit prüfen

Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis

Journal of magnetic resonance imaging, 2012-06, Vol.35 (6), p.1300-1311

2012

Link zum Volltext

Verfügbarkeit prüfen

Evolving expectations around early management of multiple sclerosis

Therapeutic Advances in Neurological Disorders, 2010-11, Vol.3 (6), p.351-367

2010

Link zum Volltext

Verfügbarkeit prüfen

Proton magnetic resonance spectroscopy in multiple sclerosis

Neuroimaging clinics of North America, 2009-02, Vol.19 (1), p.45

2009

Link zum Volltext

Verfügbarkeit prüfen

Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: Implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS

Journal of the neurological sciences, 2012-02, Vol.313 (1), p.99-109

2012

Link zum Volltext

Verfügbarkeit prüfen

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.209-220

2017

Link zum Volltext

Verfügbarkeit prüfen

Mr-derived cerebral spinal fluid hydrodynamics as a marker and a risk factor for intracranial hypertension in astronauts exposed to microgravity

Journal of magnetic resonance imaging, 2015-12, Vol.42 (6), p.1560-1571

2015

Link zum Volltext

Verfügbarkeit prüfen

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

Brain (London, England : 1878), 2019-09, Vol.142 (9), p.2787-2799

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

Neurology, 2021-10, Vol.97 (16), p.e1546

2021

Link zum Volltext

Verfügbarkeit prüfen

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.221-234

2017

Link zum Volltext

Verfügbarkeit prüfen

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

Multiple sclerosis, 2019-12, Vol.25 (14), p.1915-1925

2019

Link zum Volltext

Verfügbarkeit prüfen

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis

The New England journal of medicine, 2018-09, Vol.379 (11), p.1017-1027

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 289

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(195)
Humans
(158)
Neurosciences & Neurology
(140)
Clinical Neurology
(130)
Multiple Sclerosis
(107)
Male
(96)
Female
(91)
Adult
(90)
Neurosciences
(88)
Middle Aged
(74)
Biological And Medical Sciences
(67)
Magnetic Resonance Imaging
(67)
Neurology
(63)
Medical Sciences
(55)
Brain - Pathology
(34)
Radiology, Nuclear Medicine & Medical Imaging
(31)
Double-Blind Method
(30)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(29)
Animals
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosis

Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis

Deep gray matter atrophy in multiple sclerosis: A tensor based morphometry

Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis

Evolving expectations around early management of multiple sclerosis

Proton magnetic resonance spectroscopy in multiple sclerosis

Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: Implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Mr-derived cerebral spinal fluid hydrodynamics as a marker and a risk factor for intracranial hypertension in astronauts exposed to microgravity

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Suchergebnisse filtern